German (DAX) Healthtech Industry Analysis

Industry Valuation and Performance

Has the German Healthtech Industry valuation changed over the past few years?

Date	Market Cap	Revenue	Earnings	PE	Absolute PE	PS
Tue, 23 Jun 2026	€1.6b	€1.3b	€35.0m	31.2x	45.6x	1.2x
Thu, 21 May 2026	€1.6b	€1.3b	€36.8m	22.2x	43.4x	1.2x
Sat, 18 Apr 2026	€1.6b	€1.3b	€36.5m	13x	43.2x	1.2x
Mon, 16 Mar 2026	€1.6b	€1.3b	€37.1m	15.2x	43x	1.2x
Wed, 11 Feb 2026	€1.6b	€1.3b	€27.1m	14x	57.9x	1.2x
Fri, 09 Jan 2026	€1.5b	€1.3b	€28.3m	11.1x	51.8x	1.1x
Sun, 07 Dec 2025	€1.4b	€1.3b	€28.4m	10.5x	48.3x	1.1x
Tue, 04 Nov 2025	€1.4b	€1.3b	€28.4m	10.5x	49x	1.1x
Thu, 02 Oct 2025	€1.4b	€1.3b	€27.8m	12.4x	49.9x	1.1x
Sat, 30 Aug 2025	€1.3b	€1.3b	€27.8m	11.6x	46.3x	1x
Mon, 28 Jul 2025	€1.3b	€1.3b	€36.6m	12x	35.4x	1x
Wed, 25 Jun 2025	€1.3b	€1.3b	€36.6m	11.4x	35.3x	1x
Fri, 23 May 2025	€1.3b	€1.3b	€36.8m	11.5x	34.1x	1x
Sun, 20 Apr 2025	€2.4b	€1.5b	€75.2m	21.7x	32.5x	1.6x
Tue, 18 Mar 2025	€2.5b	€1.5b	€72.4m	27x	34x	1.6x
Thu, 13 Feb 2025	€2.5b	€1.5b	€58.9m	32.4x	42.6x	1.6x
Sat, 11 Jan 2025	€2.4b	€1.5b	€60.1m	31.4x	40.1x	1.6x
Mon, 09 Dec 2024	€2.1b	€1.5b	€60.1m	24.8x	35.4x	1.4x
Wed, 06 Nov 2024	€2.0b	€1.5b	€66.3m	20.7x	30.2x	1.3x
Fri, 04 Oct 2024	€1.8b	€1.5b	€66.3m	19.8x	26.6x	1.2x
Sun, 01 Sep 2024	€1.7b	€1.5b	€66.1m	21x	26.1x	1.1x
Tue, 30 Jul 2024	€2.4b	€1.6b	€61.4m	21.4x	38.3x	1.5x
Thu, 27 Jun 2024	€2.8b	€1.6b	€79.4m	18.5x	34.7x	1.7x
Sat, 25 May 2024	€2.9b	€1.6b	€71.3m	20.1x	41.3x	1.8x
Mon, 22 Apr 2024	€2.9b	€1.6b	€66.3m	20.3x	43.5x	1.8x
Wed, 20 Mar 2024	€2.8b	€1.6b	€69.9m	17.3x	40.5x	1.8x
Fri, 16 Feb 2024	€3.1b	€1.6b	€71.1m	15.3x	43x	1.9x
Sun, 14 Jan 2024	€3.2b	€1.6b	€101.3m	15.1x	32.1x	2x
Tue, 12 Dec 2023	€3.1b	€1.6b	€100.8m	16.2x	31x	1.9x
Thu, 09 Nov 2023	€3.0b	€1.6b	€114.2m	16.2x	26.5x	1.9x
Sat, 07 Oct 2023	€3.1b	€1.6b	€111.3m	16.2x	27.5x	1.9x
Mon, 04 Sep 2023	€3.6b	€1.6b	€116.4m	18.8x	30.8x	2.2x
Wed, 02 Aug 2023	€3.8b	€1.6b	€96.8m	19.5x	39x	2.4x
Fri, 30 Jun 2023	€3.7b	€1.6b	€96.8m	22.1x	37.8x	2.3x

Current Industry PE

Investors are optimistic on the German Healthcare Services industry, and appear confident in long term growth rates.

The industry is trading at a PE ratio of 45.6x which is higher than its 3-year average PE of 38.5x.

The 3-year average PS ratio of 1.5x is higher than the industry's current PS ratio of 1.2x.

Past Earnings Growth

The earnings for companies in the Healthcare Services industry have declined 29% per year over the last three years,
Revenues have also declined 5.3% per year.
This means overall sales from these companies are declining and profits are subsequently falling as well.

Industry Trends

Which industries have driven the changes within the German Healthcare industry?


DE Market	-0.24%
Healthcare	-0.14%
Healthtech	1.21%
Healthtech	1.21%

Industry PEThere are no additional sub-industries under this industry.

Forecasted GrowthThere are no additional sub-industries under this industry.

	Company	Last Price	7D	1Y	Valuation
	SBE Leo International Precision Health	€20.40	2.0% +€230.4k	140.0%	n/a

Company

Last Price

Valuation

SBE Leo International Precision Health

€20.40

2.0%
+€230.4k

140.0%

n/a

New minor risk - Shareholder dilution

The company's shareholders have been diluted in the past year. Increase in shares outstanding: 15% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks No financial data reported. Share price has been highly volatile over the past 3 months (59% average weekly change). Minor Risks Shareholders have been diluted in the past year (15% increase in shares outstanding). Market cap is less than US$100m (€11.5m market cap, or US$13.4m).

German (DAX) Healthtech Industry Analysis

Industry Valuation and Performance

Industry Trends

Top Stock Gainers and Losers

Latest News

New minor risk - Share price stability

Upcoming dividend of €1.00 per share

High number of new and inexperienced directors

New minor risk - Shareholder dilution